CPLANE1
protein-codingciliogenesis and planar polarity effector complex subunit 1, the group of Ciliogenesis and planar polarity effector complex subunits
Gene summary
The protein encoded by this gene has putative coiled-coil domains and may be a transmembrane protein. Defects in this gene are a cause of Joubert syndrome (JBTS). [provided by RefSeq, May 2012]
- C5orf42
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~143.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010176
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010176
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013824
Submitter: ClinGen
CPLANE1 was first reported in relation to autosomal recessive Joubert syndrome 17 in 2012 (Srour et al., PMID:22425360). Joubert syndrome 17 is caused by homozygous or compound heterozygous variants in CPLANE1 on chromosome 5p13.2 and is characterized by a distinctive congenital malformation of the brainstem and agenesis or hypoplasia of the cerebellar vermis, referred to as the molar tooth sign (MTS). Additionally, these findings are accompanied by hypotonia, cerebellar ataxia, developmental delays, abnormal respiratory pattern, and/or oculomotor apraxia. CPLANE1 has been noted to be associated with the following disease entities: Orofaciodigital syndrome type IV and Joubert Syndrome 17. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, or phenotypic variability. Orofaciodigital syndrome was shown to be a very rare subtype of Joubert syndrome 17 characterized by the neurological features of JS associated with orofacial anomalies, mesoaxial or preaxial polydactyly, Y-shaped metacarpals, and hypothalamic hamartomas. Therefore, the following disease entities have been lumped into one disease entity, Joubert Syndrome 17 (OMIM:614615). At least 30 variants (missense, nonsense, frameshift, deletion, duplication, and splice site) have been reported in 21 probands across 4 publications (PMID: 22425360; Lopez et al., 2014, PMID: 24178751; Liu et al., 2020, PMID: 32233090; Zhang et al., 2021, PMID: 33822487) and included in this curation. The mechanism for disease has been noted to be loss of function, and it is suggested that at least one truncating mutation is needed to induce the phenotype. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by animal models, functional alteration studies, and rescue models. (Damerla et al., 2015, PMID: 25877302; Toriyama et al., 2016, PMID: 27158779). Mutant 'Hug' mice harboring a S253P variant at a highly conserved residue in the mouse homolog of CPLANE1 (2410089e03rik) were show to recapitulate phenotypes observed in Joubert syndrome 17 patients, including cleft lip/pallet, polydactyly, defects in the cerebellum, and cilia transition zone defects. Additionally, fibroblasts generated from an individual with Joubert syndrome with compound heterozygous JBTS17 variants demonstrated a lack of primary cilia formation compared to 90% ciliation in normal human fibroblast cells from a healthy control subject. Finally, full length WT-Jbts17 rescued the neural tube defects, ciliogenesis defects, and the loss of IFT-A basal body recruitment resulting from MO-based knockdown in Xenopus. In summary, there is definitive evidence to support the relationship between CPLANE1 and autosomal recessive Joubert Syndrome 17. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date 12.17.2021 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0013824
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0013824
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0013824
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0010176
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013824
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018772
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Genitourinary; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: The condition may involve multi-systemic manifestations, and surveillance and avoidance of certain medications (eg, nephrotoxic agents) may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CPLANE1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001384732.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 28 | 500 | 6 | 536 | |
| missense | 4 | 30 | 1076 | 101 | 6 | 1217 |
| nonsense | 56 | 52 | 5 | 1 | 114 | |
| start loss | 1 | 1 | ||||
| frameshift | 86 | 87 | 6 | 179 | ||
| splice donor/acceptor (+/-2bp) | 9 | 56 | 12 | 77 | ||
| Total | 155 | 228 | 1127 | 602 | 12 | 2124 |
Highest pathogenic variant AF is 0.0007644464
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001371661.1 | 52 | MANE Select | |
| Ensembl | ENSP00000498265.2 | 52 | MANE Select | |
| RefSeq | NP_075561.3 | 51 | Standard | |
| Ensembl | ENSP00000389014.3 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- establishment of planar polarity
- kidney development
- ventricular septum development
- heart development
- cerebellum development
Cellular Component
- integral component of membrane
- ciliary transition zone
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000425232
- Coding exons
- 51
- Length
- 143201
- Individuals with no LoFs
- 125501
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 246
- Defined
- 125747
- p
- 0.000979
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.93 | 1307 | 1.52e+3 | 0.860 | 0.0000750 | 20974 |
| Missense (PolyPhen) | 308 | 406.02 | 0.75859 | 5940 | ||
| Synonymous | 1.27 | 505 | 543 | 0.931 | 0.0000282 | 5974 |
| Loss of Function | 4.92 | 82 | 146 | 0.561 | 0.00000708 | 2047 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00094 | 0.00092 | rare |
| Latino/Admixed American | 0.00069 | 0.00067 | rare |
| Ashkenazi Jewish | 0.00040 | 0.00040 | rare |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.00052 | 0.00051 | rare |
| European (Non-Finnish) | 0.0014 | 0.0013 | notable |
| South Asian | 0.00082 | 0.00078 | rare |
| Other | 0.0018 | 0.0016 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in ciliogenesis (PubMed:25877302). Involved in the establishment of cell polarity required for directional cell migration. Proposed to act in association with the CPLANE (ciliogenesis and planar polarity effectors) complex. Involved in recruitment of peripheral IFT-A proteins to basal bodies (By similarity). {ECO:0000250|UniProtKB:Q8CE72, ECO:0000305|PubMed:25877302}.;
- Disease
- DISEASE: Joubert syndrome 17 (JBTS17) [MIM:614615]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:22425360, ECO:0000269|PubMed:23012439, ECO:0000269|PubMed:26477546}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Orofaciodigital syndrome 6 (OFD6) [MIM:277170]: A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD6 is characterized by metacarpal abnormalities with central polydactyly, cerebellar abnormalities including the molar tooth sign, tongue hamartomas, additional frenula, and upper lip notch. {ECO:0000269|PubMed:24178751, ECO:0000269|PubMed:25846457, ECO:0000269|PubMed:27081551}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- RVIS EVS
- -0.55
- RVIS percentile EVS
- 19.94